Compound Detail
CHEMBL5184610
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCOc1cc2ncnc(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C
Basic Information
| ChEMBL ID | CHEMBL5184610 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RCXKACUHTAVIBD-ZQAUEJBPSA-N |
4
Targets
4
Activities
1
Assay Types
16
PK Parameters
7
Publications
0
Known Names
Molecular Properties
565.6
MW (Da)
4.90
ALogP
11
HBA
2
HBD
131.7
PSA (Ų)
0.24
QED
2
Ro5 Violations
9
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 8.95
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NCI-N87 CHEMBL614197 | IC50 | 8.95 | 8.95 | 1.1 | 1 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 8.87 | 8.87 | 1.4 | 1 |
| Receptor tyrosine-protein kinase erbB-2 CHEMBL1824 | IC50 | 8.78 | 8.78 | 1.7 | 1 |
| BT-474 CHEMBL614529 | IC50 | 8.67 | 8.67 | 2.1 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1700.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 2170.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 1.81 | mL.min-1.g-1 | Homo sapiens |
| CL | 1.32 | L/Kg.hr | Mus musculus |
| CL | 3.33 | L/Kg.hr | Rattus norvegicus |
| Cmax | 707.16 | nM | Mus musculus |
| Cmax | 495.01 | nM | Rattus norvegicus |
| F | 22.6 | % | Mus musculus |
| F | 47.48 | % | Rattus norvegicus |
| T1/2 | 12.95 | hr | Homo sapiens |
| T1/2 | 4.38 | hr | Mus musculus |
| T1/2 | 3.07 | hr | Mus musculus |
| T1/2 | 2.09 | hr | Rattus norvegicus |
| T1/2 | 4.32 | hr | Rattus norvegicus |
| Tmax | 1.67 | hr | Mus musculus |
| Tmax | 4.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NCI-N87 | IC50 | = | 1.12 | nM | 8.95 | Antiproliferative activity against human NCI-N87 cells assessed as inhibition of... | 35319895 |
| Epidermal growth factor receptor | IC50 | = | 1.36 | nM | 8.87 | Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) ... | 35319895 |
| Receptor tyrosine-protein kinase erbB-2 | IC50 | = | 1.67 | nM | 8.78 | Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in... | 35319895 |
| BT-474 | IC50 | = | 2.13 | nM | 8.67 | Antiproliferative activity against human BT-474 cells assessed as inhibition of ... | 35319895 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35319895 | 10.1021/acs.jmedchem.1c00710 | ADMET | 18 |
| 35319895 | 10.1021/acs.jmedchem.1c00710 | Receptor tyrosine-protein kinase erbB-2 | 3 |
| 35319895 | 10.1021/acs.jmedchem.1c00710 | Epidermal growth factor receptor | 1 |
| 35319895 | 10.1021/acs.jmedchem.1c00710 | Unchecked | 1 |
| 35319895 | 10.1021/acs.jmedchem.1c00710 | NCI-N87 | 1 |
| 35319895 | 10.1021/acs.jmedchem.1c00710 | BT-474 | 1 |
| 35319895 | 10.1021/acs.jmedchem.1c00710 | Cytochrome P450 2D6 | 1 |
Data from ChEMBL 36 via Core Engine